In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria.

PubWeight™: 2.13‹?› | Rank: Top 2%

🔗 View Article (PMC 180325)

Published in Antimicrob Agents Chemother on December 01, 1985

Authors

M A Cohen, T J Griffin, P A Bien, C L Heifetz, J M Domagala

Articles citing this

In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents. Antimicrob Agents Chemother (1986) 2.04

In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother (1986) 1.79

Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents. J Clin Microbiol (1987) 1.65

In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains. Antimicrob Agents Chemother (1988) 1.58

Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci. Antimicrob Agents Chemother (1992) 1.52

Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Antimicrob Agents Chemother (1996) 1.46

In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy. Antimicrob Agents Chemother (1989) 1.17

Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci. Antimicrob Agents Chemother (1994) 1.04

Rate of bactericidal activity for Streptococcus faecalis of a new quinolone, CI-934, compared with that of amoxicillin. Antimicrob Agents Chemother (1986) 0.80

Code names for new compounds. Antimicrob Agents Chemother (1986) 0.75

Articles by these authors

Exhaustive matching of the entire protein sequence database. Science (1992) 11.29

Amino acid substitution during functionally constrained divergent evolution of protein sequences. Protein Eng (1994) 9.42

Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41

Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62

FKF1, a clock-controlled gene that regulates the transition to flowering in Arabidopsis. Cell (2000) 3.38

Correct structure prediction? Nature (1992) 3.19

Butirosin, a new aminoglycosidic antibiotic complex: antibacterial activity in vitro and in mice. Antimicrob Agents Chemother (1972) 3.04

New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J Med Chem (1986) 2.24

Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids. J Med Chem (1988) 2.21

Communication skills of house officers. A study in a medical clinic. Ann Intern Med (1980) 2.12

Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol (1995) 2.09

Empirical and structural models for insertions and deletions in the divergent evolution of proteins. J Mol Biol (1993) 1.98

Comparison of microdilution and agar dilution procedures for testing antibiotic susceptibility of Neisseria gonorrhoeae. J Clin Microbiol (1984) 1.97

Should a psychiatrist report a bus driver's alcohol and drug abuse? An ethical dilemma. Gen Hosp Psychiatry (2001) 1.95

Purification and properties of the periplasmic glucose-binding protein of Pseudomonas aeruginosa. J Bacteriol (1977) 1.85

Victim costs of violent crime and resulting injuries. Health Aff (Millwood) (1993) 1.80

Is there a causal relationship between alcohol use and violence? A synthesis of evidence. Recent Dev Alcohol (1997) 1.78

Post-traumatic parotid sialocele: report of two cases. J Oral Maxillofac Surg (1999) 1.76

Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71

In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent. Antimicrob Agents Chemother (1991) 1.67

Impact of core biopsy on the surgical management of impalpable breast cancer. AJR Am J Roentgenol (1997) 1.63

The synthesis, structure-activity, and structure-side effect relationships of a series of 8-alkoxy- and 5-amino-8-alkoxyquinolone antibacterial agents. J Med Chem (1995) 1.49

Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7. J Med Chem (1996) 1.48

Pleomorphic adenoma of the cheek. Int J Oral Maxillofac Surg (1986) 1.48

Neural dynamics of brightness perception: features, boundaries, diffusion, and resonance. Percept Psychophys (1984) 1.47

Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Antimicrob Agents Chemother (1996) 1.46

The determinants of spatial distribution of hospital utilization in a region. Med Care (1985) 1.41

Core needle biopsy of synchronous ipsilateral breast lesions: impact on treatment. AJR Am J Roentgenol (1996) 1.39

A retrospective study of community-acquired pneumonia in Hong Kong with special reference to the choice of antibiotics. Singapore Med J (1989) 1.38

Isolation of dicarboxylic acid- and glucose-binding proteins from Pseudomonas aeruginosa. J Bacteriol (1976) 1.35

In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagn Microbiol Infect Dis (1991) 1.31

Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology (1995) 1.27

Life Care at Home: a new model for financing and delivering long-term care. Inquiry (1987) 1.22

Client-related risk factors of nursing home entry among elderly adults. J Gerontol (1986) 1.20

Benign and malignant phyllodes tumors: mammographic and sonographic findings. Radiology (1996) 1.18

Radiation-induced osteochondromas. Radiology (1982) 1.17

Huge growth potential of the nasolabial cyst. Oral Surg Oral Med Oral Pathol (1985) 1.16

Perirectal abscess. Ann Emerg Med (1995) 1.14

Predicted secondary structure for the Src homology 3 domain. J Mol Biol (1993) 1.13

Effects of categorization and discrimination training on auditory perceptual space. J Acoust Soc Am (1999) 1.12

The lifetime risks and costs of nursing home use among the elderly. Med Care (1986) 1.11

Chemical and kinetic mechanism of the inositol monophosphatase reaction and its inhibition by Li+. Eur J Biochem (1993) 1.09

Impact of stereotaxic core breast biopsy on cost of diagnosis. Radiology (1995) 1.09

Penetrating injuries to the maxillofacial region. J Oral Maxillofac Surg (1986) 1.07

Localized anterior arthrofibrosis (cyclops lesion) after reconstruction of the anterior cruciate ligament: MR imaging findings. AJR Am J Roentgenol (1995) 1.06

Apathetic hyperthyroidism in middle age. Int J Psychiatry Med (1991) 1.06

Palatoplasty: Furlow's double reversing Z-plasty versus intravelar veloplasty. Cleft Palate Craniofac J (1998) 1.05

Analysis of capacity decisions for progressive patient care hospital facilities. Health Serv Res (1980) 1.05

Bona fide prediction of aspects of protein conformation. Assigning interior and surface residues from patterns of variation and conservation in homologous protein sequences. J Mol Biol (1994) 1.05

Costs of gunshot and cut/stab wounds in the United States, with some Canadian comparisons. Accid Anal Prev (1997) 1.04

A stochastic service network model with application to hospital facilities. Oper Res (1981) 1.04

Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates. J Antimicrob Chemother (1988) 1.03

1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials. J Med Chem (1988) 1.02

Analysis of amino acid substitution during divergent evolution: the 400 by 400 dipeptide substitution matrix. Biochem Biophys Res Commun (1994) 1.02

Stimulation of precise excision and recombination by conjugal proficient F'plasmids. Mol Gen Genet (1986) 1.00

Mutation of Bacillus firmus OF4 to duramycin resistance results in substantial replacement of membrane lipid phosphatidylethanolamine by its plasmalogen form. J Bacteriol (1989) 1.00

In vitro transposition system for efficient generation of random mutants of Campylobacter jejuni. J Bacteriol (2001) 1.00

Plastic bullet injuries of the face and jaws. S Afr Med J (1985) 0.99

Preoperative galactography increases the diagnostic yield of major duct excision for nipple discharge. Cancer (1998) 0.99

The financial capacity of the elderly to insure for long-term care. Gerontologist (1987) 0.99

In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria. Diagn Microbiol Infect Dis (1992) 0.99

Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria. J Med Chem (1995) 0.99

Butirosin compared with gentamicin in vitro and in vivo. Antimicrob Agents Chemother (1974) 0.99

New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk. J Med Chem (1992) 0.97

Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity. J Med Chem (1992) 0.96

Noise exposure and hearing loss prevention programmes after 20 years of regulations in the United States. Occup Environ Med (2006) 0.96

Tn552 transposase catalyzes concerted strand transfer in vitro. Proc Natl Acad Sci U S A (1998) 0.96

A metaproteomic analysis of the human salivary microbiota by three-dimensional peptide fractionation and tandem mass spectrometry. Mol Oral Microbiol (2010) 0.96

Inhalation of products of combustion. Ann Emerg Med (1983) 0.96

Early life and later determinants of adult disease: a 50 year follow-up study of the Newcastle Thousand Families cohort. Public Health (1998) 0.95

New directions in life care: an industry in transition. Milbank Q (1987) 0.95

Comparative chemotherapeutic activity of new fluorinated 4-quinolones and standard agents against a variety of bacteria in a mouse infection model. J Antimicrob Chemother (1989) 0.94

Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin. J Clin Microbiol (1992) 0.94

Comparative in-vitro activity of enoxacin against penicillinase- and non-penicillinase-producing Neisseria gonorrhoeae. Sex Transm Dis (1987) 0.93

The impact of PTSD on treatment adherence in persons with HIV infection. Gen Hosp Psychiatry (2001) 0.93

Androgen receptor mRNA expression in Xenopus laevis CNS: sexual dimorphism and regulation in laryngeal motor nucleus. J Neurobiol (1996) 0.93

Does the BJGP need more fizz and pop?--A Midland Faculty readership survey. Br J Gen Pract (1997) 0.92

In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency. Antimicrob Agents Chemother (1993) 0.92

Computed tomography in the diagnosis and treatment of mandibular ameloblastoma: report of cases. J Oral Maxillofac Surg (1985) 0.91

Safety and long-term effects of plasmapheresis. Transfusion (1970) 0.91

Squamous cell papilloma of the esophagus. Report of a case after peptic esophagitis and repeated bougienage with review of the literature. Gastroenterology (1978) 0.90

Disc-agar diffusion microbiological assay procedure for determining serum and urine levels of sulfacytine and other sulfonamides. Appl Microbiol (1971) 0.90

Membranes of animal cells. 8. Distribution of sialic acid, hexosamines and sialidase in the L cell. Biochim Biophys Acta (1971) 0.89

Indoor/outdoor measurements of volatile organic compounds in the Kanawha Valley of West Virginia. JAPCA (1989) 0.89

The role of essential pyrimidines in the hairpin ribozyme-catalysed reaction. J Mol Biol (1999) 0.89

Evaluation of maxillary sinus membrane response following elevation with the crestal osteotome technique in human cadavers. Int J Oral Maxillofac Implants (2001) 0.89

5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV protease. J Med Chem (2000) 0.88

Target inventory levels for a hospital blood bank or a decentralized regional blood banking system. Transfusion (1979) 0.88

Percutaneous needle biopsy in abdominal lymphoma. AJR Am J Roentgenol (1981) 0.88

In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs. J Antimicrob Chemother (1997) 0.88